Treace Medical Concepts Inc
General ticker "TMCI" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $489.1M
Treace Medical Concepts Inc does not follow the US Stock Market performance with the rate: -21.8%.
Estimated limits based on current volatility of 2.9%: low 6.84$, high 7.25$
Factors to consider:
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [5.87$, 14.56$]
- 2024-12-30 to 2025-12-30 estimated range: [5.27$, 12.65$]
Financial Metrics affecting the TMCI estimates:
- Negative: Non-GAAP EPS, $ of -0.81 <= 0.10
- Negative: Operating profit margin, % of -21.56 <= 1.03
- Negative: Operating cash flow per share per price, % of -5.41 <= 2.35
- Negative: negative Net income
- Positive: -3.48 < Investing cash flow per share, $ of -1.34
- Negative: Industry operating cash flow per share per price (median), % of -5.15 <= 3.85
- Positive: Industry inventory ratio change (median), % of 0.19 <= 0.49
Short-term TMCI quotes
Long-term TMCI plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $94.42MM | $141.84MM | $187.12MM |
| Operating Expenses | $110.93MM | $176.68MM | $238.55MM |
| Operating Income | $-16.51MM | $-34.84MM | $-51.43MM |
| Non-Operating Income | $-4.04MM | $-7.97MM | $1.90MM |
| Interest Expense | $4.06MM | $4.40MM | $5.17MM |
| R&D Expense | $10.20MM | $13.58MM | $15.44MM |
| Income(Loss) | $-20.55MM | $-42.81MM | $-49.53MM |
| Taxes | $4.06MM | $4.48MM | $0.00MM |
| Profit(Loss) | $-24.61MM | $-47.30MM | $-49.53MM |
| Stockholders Equity | $93.07MM | $60.53MM | $137.94MM |
| Inventory | $10.56MM | $19.33MM | $29.25MM |
| Assets | $140.82MM | $159.02MM | $251.91MM |
| Operating Cash Flow | $-17.19MM | $-30.65MM | $-34.58MM |
| Capital expenditure | $2.71MM | $14.84MM | $11.46MM |
| Investing Cash Flow | $-2.71MM | $-76.52MM | $-81.30MM |
| Financing Cash Flow | $107.65MM | $20.81MM | $109.38MM |
| Earnings Per Share* | $-0.45 | $-0.86 | $-0.81 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.